The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Emerging cell and cytokine targets in rheumatoid arthritis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Amara, K., Steen, J., Murray, F., Morbach, H., Fernandez-Rodriguez, B. M., Joshua, V., Engström, M., Snir, O., Israelsson, L., Catrina, A. I., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121486 · Cited by 195
RetractedThe Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529
Nielen, M. M. J., van Schaardenburg, D., Reesink, H. W., van de Stadt, R. J., van der Horst‐Bruinsma, I. E., de Koning, M. H. M. T., Habibuw, M. R., Vandenbroucke, J. P., & Dijkmans, B. A. C. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20018 · Cited by 1,861
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
Jones, R. B., Cohen Tervaert, J. W., Hauser, T., Luqmani, R., Morgan, M. D., Peh, C. A., Savage, C. O., Segelmark, M., Tesar, V., van Paassen, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909169 · Cited by 1,748
Cohen, S. B., Emery, P., Greenwald, M. W., Dougados, M., Furie, R. A., Genovese, M. C., Keystone, E. C., Loveless, J. E., Burmester, G., Cravets, M. W., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22025 · Cited by 1,638
Self-citationHueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
Interleukin-17 and Type 17 Helper T Cells
Miossec, P., Korn, T., & Kuchroo, V. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0707449 · Cited by 1,409
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., & Mauri, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040165 · Cited by 1,252
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., et al. (2000) · Nature · doi:10.1038/35010115 · Cited by 1,174
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
Koreth, J., Matsuoka, K.-I., Kim, H. T., McDonough, S. M., Bindra, B., Alyea, E. P., Armand, P., Cutler, C., Ho, V. T., Treister, N. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108188 · Cited by 1,119
Iwata, Y., Matsushita, T., Horikawa, M., DiLillo, D. J., Yanaba, K., Venturi, G. M., Szabolcs, P. M., Bernstein, S. H., Magro, C. M., Williams, A. D., et al. (2011) · Blood · doi:10.1182/blood-2010-07-294249 · Cited by 1,104
Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
Bargou, R., Leo, E., Zugmaier, G., Klinger, M., Goebeler, M., Knop, S., Noppeney, R., Viardot, A., Hess, G., Schuler, M., et al. (2008) · Science · doi:10.1126/science.1158545 · Cited by 1,078
Characterization of a human B lymphocyte-specific antigen.
Stashenko, P., Nadler, L. M., Hardy, R., & Schlossman, S. F. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.4.1678 · Cited by 1,076
Emery, P., Fleischmann, R., Filipowicz‐Sosnowska, A., Schechtman, J., Szczepanski, L., Kavanaugh, A., Racewicz, A. J., van Vollenhoven, R. F., Li, N. F., Agarwal, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21778 · Cited by 1,060
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
JAKs and STATs in immunity, immunodeficiency, and cancer
O'Shea, J. J., Holland, S. M., & Staudt, L. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1202117 · Cited by 927
Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860
Inflammatory bone loss: pathogenesis and therapeutic intervention
Redlich, K., & Smolen, J. S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3669 · Cited by 830
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Buckner, J. H. (2010) · Nature Reviews Immunology · doi:10.1038/nri2889 · Cited by 789
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
Saadoun, D., Rosenzwajg, M., Joly, F., Six, A., Carrat, F., Thibault, V., Sene, D., Cacoub, P., & Klatzmann, D. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105143 · Cited by 762
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome
Groom, J., Kalled, S. L., Cutler, A. H., Olson, C., Woodcock, S. A., Schneider, P., Tschopp, J., Cachero, T. G., Batten, M., Wheway, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214121 · Cited by 712
Flores-Borja, F., Bosma, A., Ng, D., Reddy, V., Ehrenstein, M. R., Isenberg, D. A., & Mauri, C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005407 · Cited by 688
Mechanisms of killing by anti-CD20 monoclonal antibodies
Glennie, M. J., French, R. R., Cragg, M. S., & Taylor, R. P. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.151 · Cited by 515
Immunity to Citrullinated Proteins in Rheumatoid Arthritis
Klareskog, L., Rönnelid, J., Lundberg, K., Padyukov, L., & Alfredsson, L. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090244 · Cited by 463
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Buch, M. H., Smolen, J. S., Betteridge, N., Breedveld, F. C., Burmester, G., Dörner, T., Ferraccioli, G., Gottenberg, J.-E., Isaacs, J., Kvien, T. K., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.144998 · Cited by 453
Self-citationGenovese, M. C., Van den Bosch, F., Roberson, S. A., Bojin, S., Biagini, I. M., Ryan, P., & Sloan‐Lancaster, J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27334 · Cited by 451
Th17 and natural Treg cell population dynamics in systemic lupus erythematosus
Yang, J., Chu, Y., Yang, X., Gao, D., Zhu, L., Yang, X., Wan, L., & Li, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24499 · Cited by 444
Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment
Nistala, K., Adams, S., Cambrook, H., Ursu, S., Olivito, B., de Jager, W., Evans, J. G., Cimaz, R., Bajaj-Elliott, M., & Wedderburn, L. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003852107 · Cited by 443
Cao, D., Malmström, V., Baecher‐Allan, C., Hafler, D., Klareskog, L., & Trollmo, C. (2003) · European Journal of Immunology · doi:10.1002/immu.200390024 · Cited by 439
Rheumatoid arthritis progression mediated by activated synovial fibroblasts
Neumann, E., Lefèvre, S., Zimmermann, B., Gay, S., & Müller-Ladner, U. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.004 · Cited by 394
An overview of IL-17 function and signaling
Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.017 · Cited by 382
Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents
Cragg, M. S., & Glennie, M. J. (2004) · Blood · doi:10.1182/blood-2003-06-2031 · Cited by 360
Wallace, D. J., Kalunian, K., Petri, M. A., Strand, V., Houssiau, F. A., Pike, M., Kilgallen, B., Bongardt, S., Barry, A., Kelley, L., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202760 · Cited by 337
Möttönen, M., Heikkinen, J., Mustonen, L., Isomäki, P., Luukkainen, R., & Lassila, O. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02754.x · Cited by 320
Plasticity of CD4+ FoxP3+ T cells
Zhou, X., Bailey-Bucktrout, S., Jeker, L. T., & Bluestone, J. A. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.007 · Cited by 317
The Structure of the GM-CSF Receptor Complex Reveals a Distinct Mode of Cytokine Receptor Activation
Hansen, G., Hercus, T. R., McClure, B. J., Stomski, F. C., Dottore, M., Powell, J., Ramshaw, H., Woodcock, J. M., Xu, Y., Guthridge, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.05.053 · Cited by 311
CD25+ cell depletion hastens the onset of severe disease in collagen‐induced arthritis
Morgan, M. E., Sutmuller, R. P. M., Witteveen, H. J., van Duivenvoorde, L. M., Zanelli, E., Melief, C. J. M., Snijders, A., Offringa, R., de Vries, R. R. P., & Toes, R. E. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11063 · Cited by 305
The central role of T cells in rheumatoid arthritis.
Cope, A. P., Schulze‐Koops, H., & Aringer, M. (2007) · PubMed · Cited by 300
Alduaij, W., Ivanov, A., Honeychurch, J., Cheadle, E. J., Potluri, S., Lim, S. H., Shimada, K., Chan, C. H. T., Tutt, A., Beers, S. A., et al. (2011) · Blood · doi:10.1182/blood-2010-07-296913 · Cited by 294
Genovese, M. C., Durez, P., Richards, H. B., Supronik, J., Dokoupilova, E., Mazurov, V., Aelion, J. A., Lee, S.-H., Codding, C. E., Kellner, H., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201601 · Cited by 293
Horton, H. M., Bernett, M. J., Pong, E., Peipp, M., Karki, S., Chu, S. Y., Richards, J. O., Vostiar, I., Joyce, P. F., Repp, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2268 · Cited by 272
Sato, S., Ono, N., Steeber, D. A., Pisetsky, D. S., & Tedder, T. F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4371 · Cited by 267
Roschke, V., Sosnovtseva, S., Ward, C. D., Hong, J. S., Smith, R., Albert, V., Stohl, W., Baker, K. P., Ullrich, S., Nardelli, B., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4314 · Cited by 259
Rich, P., Sigurgeirsson, B., Thaçi, D., Ortonne, J. ‐., Paul, C. F., Schopf, R. E., Morita, A., Roseau, K., Harfst, E., Guettner, A., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12112 · Cited by 244
Lawson, C. A., Brown, A. K., Bejarano, V., Douglas, S. H., Burgoyne, C. H., Greenstein, A. S., Boylston, A. W., Emery, P., Ponchel, F., & Isaacs, J. D. (2006) · Rheumatology · doi:10.1093/rheumatology/kel089 · Cited by 234
Singh, J. A., Christensen, R., Wells, G. A., Suarez-Almazor, M. E., Buchbinder, R., Lopez-Olivo, M. A., Ghogomu, E. T., & Tugwell, P. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.091391 · Cited by 229
Expression of cell surface markers after human B lymphocyte activation.
Stashenko, P., Nadler, L. M., Hardy, R., & Schlossman, S. F. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3848 · Cited by 212
Ohata, J., Zvaifler, N. J., Nishio, M., Boyle, D. L., Kalled, S. L., Carson, D. A., & Kipps, T. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.864 · Cited by 211
Rich, P., Sigurgeirsson, B., Thaci, D. P., Ortonne, J.-P., Paul, C., Schopf, R. E., Morita, A., Roseau, K., Harfst, E., Guettner, A., et al. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12070 · Cited by 189
CD22: A Multifunctional Receptor That Regulates B Lymphocyte Survival and Signal Transduction
Tedder, T. F., Poe, J. C., & Haas, K. M. (2005) · Advances in Immunology · doi:10.1016/s0065-2776(05)88001-0 · Cited by 185
Regulatory B cells in autoimmunity: developments and controversies
Mauri, C., & Blair, P. A. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.140 · Cited by 181
IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity
Ochs, H. D., Gambineri, E., & Torgerson, T. R. (2007) · Immunologic Research · doi:10.1007/s12026-007-0022-2 · Cited by 176
B-cell-directed therapies for autoimmune disease
Dörner, T., Radbruch, A., & Burmester, G. R. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.141 · Cited by 175
Self-citationEfficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
Burmester, G. R., Weinblatt, M. E., McInnes, I. B., Porter, D. R., Барбараш, О. Л., Vatutin, M. T., Szombati, I., Esfandiari, E., Sleeman, M. A., Kane, C. D., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202450 · Cited by 172
Self-citationThe role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets
Dörner, T., & Burmester, G. R. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200305000-00011 · Cited by 164
Self-citationHan, G., O’Neil-Andersen, N. J., Zurier, R. B., & Lawrence, D. A. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2008.05.007 · Cited by 154
Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus
Alexander, T., Sattler, A., Templin, L., Köhler, S., Groß, C., Meisel, A., Sawitzki, B., Burmester, G. R., Arnold, R., Radbruch, A., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202216 · Cited by 153
Self-citationFunction of interleukin‐20 as a proinflammatory molecule in rheumatoid and experimental arthritis
Hsu, Y., Li, H. H., Hsieh, M., Liu, M.-F., Huang, K., Chin, L.-S., Chen, P., Cheng, H., & Chang, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22039 · Cited by 146
Eular Textbook on Rheumatic Diseases
Adwan, M. H. (2015) · Saudi Medical Journal · doi:10.15537/1658-3175.6383 · Cited by 145
Salliot, C., Finckh, A., Katchamart, W., Lu, Y., Sun, Y., Bombardier, C., & Keystone, E. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.132134 · Cited by 140
Frey, O., Petrow, P. K., Gajda, M. R., Siegmund, K., Huehn, J., Scheffold, A., Hamann, A., Radbruch, A., & Bräuer, R. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1484 · Cited by 129
Kwok, S., Cho, M., Park, M., Oh, H.-J., Park, J., Her, Y., Lee, S.-Y., Youn, J., Ju, J. H., Park, K. S., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33390 · Cited by 129
Taylor, P. C., Quattrocchi, E., Mallett, S. A., Kurrasch, R., Petersen, J. H., & Chang, D. J. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.151522 · Cited by 129
Jacobi, A. M., Goldenberg, D. M., Hiepe, F., Radbruch, A., Burmester, G. R., & Dörner, T. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.075762 · Cited by 127
Self-citationBurmester, G. R., Feist, E., Sleeman, M., Wang, B., White, B., & Magrini, F. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146225 · Cited by 127
Self-citationRegulatory T cells as therapeutic targets in rheumatoid arthritis
Esensten, J. H., Wofsy, D., & Bluestone, J. A. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.183 · Cited by 126
Wang, Y., Ito, S., Chino, Y., Goto, D., Matsumoto, I., 村田, 秀., Tsutsumi, A., Hayashi, T., Uchida, K., Usui, J., et al. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04031.x · Cited by 122
Dörner, T., Kinnman, N., & Tak, P. P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.001 · Cited by 122
Self-citationRationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity
Mei, H. E., Schmidt, S., & Dörner, T. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3909 · Cited by 122
Self-citationKragstrup, T. W., Otkjær, K., Holm, C. K., Jørgensen, A., Hokland, M., Iversen, L., & Deleuran, B. W. (2007) · Cytokine · doi:10.1016/j.cyto.2007.10.004 · Cited by 117
IL-21 regulates Th17 cells in rheumatoid arthritis
Niu, X., He, D., Zhang, X., Yue, T., Li, N., Zhang, J. Z., Dong, C., & Chen, G. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.01.010 · Cited by 113
Rasmussen, T. K., ANDERSEN, T., Hvid, M., Hetland, M. L., Hørslev‐Petersen, K., Stengaard‐Pedersen, K., Holm, C. K., & Deleuran, B. W. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100259 · Cited by 113
MicroRNAs in Rheumatoid Arthritis: Potential Role in Diagnosis and Therapy
Filková, M., Jüngel, A., Gay, R. E., & Gay, S. (2012) · BioDrugs · doi:10.2165/11631480-000000000-00000 · Cited by 113
CAMPATH-1H IN RHEUMATOID ARTHRITIS—AN INTRAVENOUS DOSE-RANGING STUDY
Isaacs, J. D., Manna, V. K., Rapson, N. T., Bulpitt, K. J., Hazleman, B. L., Matteson, E. L., Clair, E. W. S., Schnitzer, T. J., & JOHNSTON, J. M. (1996) · Rheumatology · doi:10.1093/rheumatology/35.3.231 · Cited by 110
Østergaard, M., Baslund, B., Rigby, W. F. C., Rojkovich, B., Jørgensen, C., Dawes, P. T., Wiell, C., Wallace, D. J., Tamer, S. C., Kastberg, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27524 · Cited by 109
The pathogenesis of rheumatoid arthritis: new insights from old clinical data?
Smolen, J. S., Aletaha, D., & Redlich, K. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.23 · Cited by 108
Daridon, C., Blaßfeld, D. A. K., Reiter, K., Mei, H. E., Giesecke‐Thiel, C., Goldenberg, D. M., Hansen, A., Hostmann, A., Frölich, D., & Dörner, T. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3179 · Cited by 108
Self-citationSkriner, K., Sommergruber, W., Tremmel, V., Fischer, I., Barta, A., Smolen, J. S., & Steiner, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119504 · Cited by 104
Komatsu, N., & Takayanagi, H. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394299-9.00002-3 · Cited by 102
The tissue architecture of synovial membranes in inflammatory and non-inflammatory joint diseases
Burmester, G. R., Locher, P., Koch, B., WINCHESTER, R. J., Dimitriu-Bona, A., Kalden, J. R., & Mohr, W. (1983) · Rheumatology International · doi:10.1007/bf00541597 · Cited by 102
Self-citationGottenberg, J., Dayer, J., Lukas, C., Ducot, B., Chiocchia, G., Cantagrel, A. G., Saraux, A., Roux‐Lombard, P., & Mariette, X. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200975 · Cited by 101
Kong, N., Lan, Q., Chen, M., Zheng, T., Su, W., Wang, J., Yang, Z., Park, R., Dagliyan, G., Conti, P. S., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201052 · Cited by 100
Tak, P. P., Balanescu, A. R., Tseluyko, V., Bojin, S., Drescher, E., Dairaghi, D. J., Miao, S., Marchesin, V., Jaén, J. C., Schall, T. J., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201605 · Cited by 100
Nuclear Receptor NR4A2 Orchestrates Th17 Cell-Mediated Autoimmune Inflammation via IL-21 Signalling
Raveney, B. J. E., Oki, S., & Yamamura, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056595 · Cited by 94
Kwan, B. C., Tam, L., Lai, K., Lai, F. M., Li, E. K.-M., Wang, G., Chow, K.-M., Li, P. K.-T., & Szeto, C. (2009) · Rheumatology · doi:10.1093/rheumatology/kep255 · Cited by 92
B-cell depletion in the treatment of lupus nephritis
Gregersen, J. W., & Jayne, D. R. W. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.141 · Cited by 88
Tregitope update: Mechanism of action parallels IVIg
Cousens, L. P., Tassone, R., Mazer, B. D., Ramachandiran, V., Scott, D. W., & Groot, A. S. D. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.08.017 · Cited by 87
Hsu, Y., Chen, W., Chan, C.-H., Wu, C., Sun, Z., & Chang, M. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20102234 · Cited by 87
Pulmonary Alveolar Proteinosis
Khan, A., & Agarwal, R. (2011) · Respiratory Care · doi:10.4187/respcare.01125 · Cited by 86
Immunopathologic role of B lymphocytes in rheumatoid arthritis: Rationale of B cell-directed therapy
Martinez‐Gamboa, L., Brezinschek, H. P., Burmester, G. R., & Dörner, T. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.02.004 · Cited by 83
Self-citationThe tissue architecture of synovial membranes in inflammatory and non-inflammatory joint diseases
Koch, B., Locher, P., Burmester, G. R., Mohr, W., & Kalden, J. R. (1984) · Rheumatology International · doi:10.1007/bf00541201 · Cited by 76
Self-citationCo-stimulatory modulation in rheumatoid arthritis: The role of (CTLA4-Ig) abatacept
Fiocco, U., Sfriso, P., Oliviero, F., Pagnin, E., Scagliori, E., Campana, C., Dainese, S., Cozzi, L., & Punzi, L. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.07.035 · Cited by 74
Tak, P. P., Mease, P. J., Genovese, M. C., Kremer, J. M., Haraoui, B. P., Tanaka, Y., Bingham, C. O., Ashrafzadeh, A., Travers, H., Safa‐Leathers, S., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33353 · Cited by 68
Antibodies to citrullinated proteins in arthritis: pathology and promise
Klareskog, L., Widhe, M., Hermansson, M., & Rönnelid, J. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282fbd22a · Cited by 65
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis
Bajpai, M., Chopra, P., Dastidar, S. G., & Ray, A. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.5.641 · Cited by 62
CD22 ligation inhibits downstream B cell receptor signaling and Ca2+ flux upon activation
Sieger, N., Fleischer, S. J., Mei, H. E., Reiter, K., Shock, A., Burmester, G. R., Daridon, C., & Dörner, T. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37818 · Cited by 61
Self-citationStohl, W., Gómez-Reino, J. J., Olech, E., Dudler, J., Fleischmann, R., Zerbini, C. A. F., Ashrafzadeh, A., Grzeschik, S. M., Bieraugel, R., Green, J., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200706 · Cited by 56
Lorenzi, A. R., Clarke-Cornwell, A. M., Wooldridge, T., Waldmann, H., Hale, G., Symmons, D. P. M., Hazleman, B. L., & Isaacs, J. D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23122 · Cited by 46
A Multitude of Kinases—Which are the Best Targets in Treating Rheumatoid Arthritis?
Lindström, T. M., & Robinson, W. H. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2010.02.005 · Cited by 40
Alemtuzumab: evidence for its potential in relapsing–remitting multiple sclerosis
Brown, J. W. L., & Coles, A. J. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s32687 · Cited by 32
Therapeutic potential of Tregs to treat rheumatoid arthritis
Wright, G. P., Stauss, H. J., & Ehrenstein, M. R. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.07.004 · Cited by 23
Smolian, H., Aurer, A., Sittinger, M., Zacher, J., Bernimoulin, J. ‐., Burmester, G. R., & Kolkenbrock, H. (2001) · Biological Chemistry · doi:10.1515/bc.2001.183 · Cited by 18
Self-citationFRI0197 NNC0109-0012 (anti-IL-20 MAB), well tolerated in patients with rheumatoid arthritis
Leszczyński, P., Eshof, M. K., Stegmann, H. V. B., Møller, N. P. H., & Graff, L. B. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-eular.2654 · Cited by 5
Cited by
TNF and ROS crosstalk in inflammation
Blaser, H., Dostert, C., Mak, T. W., & Brenner, D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.12.002 · Cited by 1,008
Regulation of tumour necrosis factor signalling: live or let die
Brenner, D., Blaser, H., & Mak, T. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3834 · Cited by 998
“Although some efforts have turned to targeting interleukins 160 , many pharmaceutical companies are focusing on improving immunosuppressive therapies that target TNF.”
BackgroundZhang, Q., Dehaini, D., Zhang, Y., Zhou, J., Chen, X., Zhang, L., Fang, R. H., Gao, W., & Zhang, L. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0254-4 · Cited by 958
Macrophage heterogeneity in the context of rheumatoid arthritis
Udalova, I. A., Mantovani, A., & Feldmann, M. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.91 · Cited by 686
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
Zhang, Q., & Vignali, D. A. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.017 · Cited by 296
Metadata
- Authors
- Burmester, G. R., Feist, E., & Dörner, T.
- Venue
- Nature Reviews Rheumatology
- Published
- 2013-11-12
- Volume
- 10
- Issue
- 2
- Pages
- 77-88
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2073791328
- Cited by
- 307
- References
- 106
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.